Hi,
Diablo Canyon did the following in our response to ANI Bulletin 11-02:
Formal Process to assess future neutron personnel dosimetry
New neutron dosimetry are tested per the NVLAP accredited dosimetry vendors
procedures. Diablo Canyon ensures that the provided neutron dosimetry is
accredited in the appropriate ANSI/HPS N13.11 performance categories for the
types of radiation at DCPP.
Formal process to evaluate design changes affecting neutron exposure.
We put a step in our plant administrative procedure governing design changes.
It requires that RP be involved in the process if a design change could affect
the neutron spectrum.
If you have any questions, please let me know.
Thanks,
Linda
Linda M. Sewell, CHP
Principal Health Physicist
Pacific Gas & Electric Company
Diablo Canyon Power Plant
MS 119/1/117
PO Box 56
Avila Beach, CA 93424
P: 805.545.4315 | F: 805.545.2618| [email protected]<mailto:[email protected]>
From: Johns, Alex M. [mailto:[email protected]]
Sent: Thursday, December 17, 2015 8:16 AM
To: [email protected]
Subject: [powernet] Neutron Information
Alert: This message originated outside of PG&E. Use caution when opening
attachments, clicking links or responding to requests for information.
*************************************
Good morning,
Salem Station is looking for some information regarding any and all responses
to ANI Bulletin 11-02.
Specifically,
· Formal process to assess future neutron personnel dosimetry.
· Formal process to assess future neutron instrumentation.
· Formal process to evaluate design changes affecting neutron exposure.
Alex Johns
Salem RPS
856.339.3909
________________________________
________________________________
The information contained in this e-mail, including any attachment(s), is
intended solely for use by the named addressee(s). If you are not the intended
recipient, or a person designated as responsible for delivering such messages
to the intended recipient, you are not authorized to disclose, copy, distribute
or retain this message, in whole or in part, without written authorization from
PSEG. This e-mail may contain proprietary, confidential or privileged
information. If you have received this message in error, please notify the
sender immediately. This notice is included in all e-mail messages leaving
PSEG. Thank you for your cooperation.